Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:52:25 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:DHR from 2023-04-25 to 2024-04-24 - 39 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-23 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2024 Results
2024-03-21 16:15U:DHRNews ReleaseDanaher Schedules First Quarter 2024 Earnings Conference Call
2024-02-27 16:15U:DHRNews ReleaseDanaher to Present at TD Cowen Health Care Conference
2024-02-22 16:15U:DHRNews ReleaseDanaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
2024-02-21 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2024-02-05 07:30U:DHRNews ReleaseDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
2024-01-30 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2023 Results
2024-01-09 07:30U:DHRNews ReleaseDanaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
2024-01-08 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2024-01-02 17:00U:DHRNews ReleaseDanaher to Present at J.P. Morgan Healthcare Conference
2023-12-21 16:30U:DHRNews ReleaseDanaher Schedules Fourth Quarter 2023 Earnings Conference Call
2023-12-13 16:06U:DHRNews ReleaseCodexis and Aldevron Enter Exclusive Licensing Agreement for Codex ‚ ® HiCap RNA Polymerase
2023-12-06 07:30U:DHRNews ReleaseDanaher Completes Acquisition of Abcam
2023-12-05 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-11-21 16:15U:DHRNews ReleaseDanaher to Present at Evercore ISI HealthCONx Conference
2023-10-31 07:30U:DHRNews ReleaseDanaher appoints Christopher Riley to Executive Vice President for Biotechnology
2023-10-24 06:00U:DHRNews ReleaseDanaher Reports Third Quarter 2023 Results
2023-09-30 08:00U:DHRNews ReleaseDanaher Corporation Completes Separation of Veralto Corporation
2023-09-26 16:15U:DHRNews ReleaseDanaher Schedules Third Quarter 2023 Earnings Conference Call
2023-09-19 07:43U:DHRNews ReleaseDanaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost
2023-09-12 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-09-12 02:01U:DHRNews ReleaseDHR DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important September 15 Deadline in Securities Class Action - DHR
2023-09-08 04:04U:DHRNews ReleaseDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Danaher Corporation with Losses of $100,000 to Contact the Firm
2023-08-31 18:00U:DHRNews ReleaseDanaher and Veralto to Webcast Investor and Analyst Meeting
2023-08-28 07:30U:DHRNews ReleaseDanaher to Acquire Abcam
2023-08-25 16:30U:DHRNews ReleaseDanaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected "When-issued" Trading of Veralto Common Stock
2023-08-16 16:30U:DHRNews ReleaseDanaher Releases 2023 Sustainability Report
2023-08-13 16:15U:DHRNews ReleaseROSEN, A RESPECTED AND LEADING FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DHR
2023-08-12 18:01U:DHRNews ReleaseROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DHR
2023-07-25 12:00U:DHRNews ReleaseBeckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
2023-07-25 11:00U:DHRNews ReleaseBeckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
2023-07-25 06:00U:DHRNews ReleaseDanaher Reports Second Quarter 2023 Results
2023-07-17 08:30U:DHRNews ReleaseBeckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test
2023-06-20 17:00U:DHRNews ReleaseDanaher Schedules Second Quarter 2023 Earnings Conference Call
2023-05-15 02:00U:DHRNews ReleaseBeckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
2023-05-09 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-05-03 18:00U:DHRNews ReleaseDanaher to Present at Bank of America Securities Health Care Conference
2023-05-01 07:32U:DHRNews ReleaseALDEVRON ANNOUNCES EXPANSION OF mRNA PRODUCTION CAPABILITY
2023-04-25 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2023 Results